Poly(lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins

Current Nanoscience

Volumn 5, Issue 1, 2009, Pages 1-14

  Stevanović, Magdalena ^a   Uskoković, Dragan ^a  

^a INSTITUTE OF TECHNICAL SCIENCES   (Serbia)

Author keywords

Drug delivery; Drug release; Micro and nanoparticles; Poly(lactide co glycolide; Vitamins delivery

Indexed keywords

ANTI-CANCER AGENTS; BONE FRACTURE; CONTROLLED DELIVERY; CONTROLLED DRUG DELIVERY SYSTEMS; CONTROLLED RELEASE; DELIVERY SYSTEMS; DRUG RELEASE; DRUG-RELEASE RATE; FOOD AND DRUG ADMINISTRATION; LACTIDE; MICRO AND NANO-PARTICLE; MICRO- AND NANOPARTICLES; POLY(DL-LACTIDE-COGLYCOLIDE); POLY(LACTIDE-CO-GLYCOLIDE; POLYLACTIDES; POLYMER MATERIALS; POLYMERIC CARRIERS; POLYMERIC PARTICLES; SIZE AND SIZE DISTRIBUTIONS; SUBMICRON; SURFACE FUNCTIONALIZATION; SURFACE MODIFICATION; WORLD HEALTH ORGANIZATION;

AMINES; ANTIBODIES; BIODEGRADABLE POLYMERS; FUNCTIONAL POLYMERS; MEDICAL APPLICATIONS; NANOPARTICLES; NUCLEIC ACIDS; NUTRITION; ORGANIC POLYMERS; POLYMERS; SUPRAMOLECULAR CHEMISTRY; TISSUE ENGINEERING; VITAMINS;

CONTROLLED DRUG DELIVERY;

ALENDRONIC ACID; ANTIBODY; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; BIOMATERIAL; CARBOMER; COPOLYMER; DIDODECYLDIMETHYLAMMONIUM BROMIDE; ESTROGEN; ETANIDAZOLE; FOLIC ACID; HORMONE; IMMUNOMODULATING AGENT; LIDOCAINE; NANOCAPSULE; NANOMATERIAL; NANOPARTICLE; NUCLEIC ACID; PACLITAXEL; PEPTIDE; POLOXAMER; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; POLYMER; POLYVINYL ALCOHOL; POVIDONE; PROTEIN; VITAMIN;

CELL ADHESION; CELL INTERACTION; COMPOSITE MATERIAL; DEGRADATION; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; EMULSION; HYDROPHILICITY; HYDROPHOBICITY; MACROMOLECULE; NANOENCAPSULATION; NANOTECHNOLOGY; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; ZETA POTENTIAL;

EID: 65949099508     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341309787314566     Document Type: Review

References (225)

1. Sahoo, S. K.; Parveen, S.; Panda, J. J. The present and future of nanotechnology in human health care. Nanomedicine, 2007, 3 (1), 20-31.
2. Park, J. H.; Lee, S.; Kim, J. H.; Park, K.; Kim, K.; Kwon, I. C. Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci., 2008, 33 (1), 113-137.
3. Sumer, B.; Gao, J. Theranostic nanomedicine for cancer. Nanomedicine, 2008, 3 (2), 137-140.
4. Besenbache, F.; Sutherland, D. S.; Hovgaard, M. B. From nanoscience to nanotechnology: Utilising the nanoscale. Toxicol. Lett., 2007, 172 (1), S34.
5. Liu, H.; Webster, T. J. Nanomedicine for implants: A review of studies and necessary experimental tools. Biomaterials, 2007, 28 (2), 354-369.
6. Vasir, J. K.; Reddy, M. K.; Labhasetwar, V. D. Nanosystems in drug targeting: opportunities and challenges. Curr. Nanosci., 2005, 1, 47-64.
7. Kabanov, A. V.; Gendelman, H. E. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci., 2007, 32 (8-9), 1054-1082.
8. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Nanomedicine: current status and future prospects. FASEB J., 2005, 19, 311-330.
9. Farokhzada, O. C.; Langer, R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliv. Rev., 2006, 58 (14), 1456-1459.
10. Uhrich, K. E.; Cannizzaro, S. M.; Langer, R. S.; Shakesheff, K. M. Polymeric systems for controlled drug release. Chem. Rev., 1999, 99 (11), 3181-3198.
11. Nafee, N.; Taetz, S.; Schneider, M.; Schaefer, U. F.; Lehr, C. M. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomed. Nanotechnol. Biol. Med., 2007, 3 (3), 173-183.
12. Pojarova, M.; Ananchenko, G. S.; Udachin, K. A.; Daroszewska, M.; Perret, F.; Coleman, A. W.; Ripmeester J. A. Solid lipid nanoparticles of p-hexanoyl calix [4] arene as a controlling agent in the photochemistry of a sunscreen blocker. Chem. Mater., 2006, 18 (25), 5817-5819.
13. Zhang, N.; Ping, Q.; Huang, G.; Xu, W.; Cheng, Y.; Han, X. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int. J. Pharm., 2006, 327 (1-2), 153-159.
14. Luo, Y. F.; Chen, D. W.; Ren, L. X.; Zhao, X. L.; Qin, J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release, 2006, 114 (1), 53-59.
15. Chen, J. F.; Ding, H. M.; Wang, J. X.; Shao, L. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials, 2004, 25 (4), 723-727.
16. Bhakta, G.; Mitra, S.; Maitra, A. DNA encapsulated magnesium and manganous phosphate nanoparticles: potential non-viral vectors for gene delivery. Biomaterials, 2005, 26 (14), 2157-2163.
17. Cavallaro, G.; Maniscalco, L.; Licciardi, M.; Giammona, G.; Tamoxifen-loaded polymeric micelles: preparation, physico-chemical characterization and in vitro evaluation studies. Macromol. Biosci., 2004, 4 (11), 1028-1038.
18. Brannon-Peppas, L.; Polymers in controlled drug delivery. Medical Plastics and Biomaterials Magazine, 1997, (http:// www.devicelink.com/mpb/archive/97/11/003.html) (accessed May 2008).
19. Nair, L. S.; Laurencin, C. T.; Biodegradable polymer as biomaterials. Prog. Polym. Sci., 2007, 32 (8-9), 762-798.
20. Zhang, H.; Cui, W.; Bei, J.; Wang, S.; Preparation of poly(lactide-coglycolide-co-caprolactone) nanoparticles and their degradation behaviour in aqueous solution. Polym. Degrad. Stab., 2006, 91 (9), 1929-1936.
21. Ajduković, Z.; Ignjatović, N.; Petrović, D.; Uskoković, D. Substitution of osteoporotic alveolar bone by biphasic calcium phosphate/poly-dl-lactide-coglycolide biomaterials. J. Biomater. Appl., 2007, 21 (3), 317-328.
22. Lademann, J.; Richter, H.; Teichmann, A.; Ottberg, N.; Blume- Peytavi, U.; Luengo, J.; Weis, B.; Schaeferb, U. F.; Lehrb, C.-M.; Wepf, R.; Sterrya W. Nanoparticles - an efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm., 2007, 66 (2), 159-164.
23. Stevanović, M.; Savić, J.; Jordović, B.; Uskoković, D. Fabrication, in vitro degradation and the release behaviours of poly(DL-lactide-co-glycolide) nanospheres containing ascorbic acid. Colloids Surf., B, 2007, 59 (2), 215-223.
24. Agrawal, C. M.; Ray, R. B. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J. Biomed. Mater. Res. A, 2003, 55 (2), 141-150.
25. Virto, M. R.; Elorza, B.; Torrado, S.; Elorza, M.; Frutos, G. Improvement of gentamicin poly(d,l-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures. Biomaterials, 2007, 28 (5), 877-885.
26. O'Hogan, D. T.; Rahman, D.; Mcgee, J. P.; Jeffery, H.; Davies, M. C.; Williams, P.; Davis, S. S.; Challacombe S. J. Biodegradable microparticles as controlled release antigen delivery systems. Immunology, 1991, 73 (2), 239-242.
27. Yoo, H. S.; Preparation of biodegradable polymeric hollow microspheres using O/O/W emulsion stabilized by Labrafil. Colloids Surf., B, 2006, 52 (1), 47-51.
28. Radić, M.; Ignjatović, N.; Nedić, Z.; Mitrić, M.; Miljković, M.; Uskoković, D. Synthesis and characterization of the composite material biphasic calcium phosphate/poly-(DL-Lactide-co-glycolide). Mater. Sci. Forum, 2005, 494, 537-542.
29. Du, J.; Fang, Y.; Zheng, Y. Synthesis and characterization of poly(l-lactic acid) reinforced by biomesogenic units. Polym. Degrad. Stab., 2008, 93 (4), 838-845.
30. Okada, H.; Toguchi, H. Biodegradable microspheres in drug delivery. Crit. Rev. Ther. Drug, 1995, 12, 1-99.
31. Kulkarni, R. K.; Pani, K. C.; Neuman, C.; Leonard, F. Polylactic acid for surgical implants. Arch. Surg. Chicago, 1966, 93, 839-843.
32. Jovanović, I.; Stevanović, M.; Nedeljković, B.; Ignjatović, N. The effect of processing parameters on characteristics of PLLA microspheres. Mater. Sci. Forum, 2007, 555, 453-457.
33. Radić, M.; Ignjatović, N.; Jugović, D.; Nedić, Z.; Mitrić, M.; Miljković, M. Synthesis of BCP and BCP/PLGA biomaterials by ultrasonic spray pyrolysis. Proceedings of the 7th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Antic-Jovanović, A.; Anić, S.; Eds; 2004, Vol. II, pp. 487-489.
34. Ignjatović, N.; Tomić, S.; Dakić, M.; Miljković, M.; Plavsić, M.; Uskoković, D. Synthesis and properties of hydroxyapatite/poly-l-lactide composite biomaterials. Biomaterials, 1999, 20 (9), 809-816.
35. Ignjatović, N.; Ajduković, Z.; Uskoković, D. New biocomposite calcium-phosphate/poly-dl-lactide-co-glicolide/ biostimulatite agens filler for reconstruction of bone tissue changed by osteoporosis. J. Mater. Sci. Mater. Med., 2005, 16 (7), 621-626.
36. Kim, S. S.; Park, M. S.; Jeon, O.; Choi, C. Y.; Kim, B. S. Poly(lactide-coglycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials, 2006, 27 (8), 1399-1409.
37. Stevanović, M.; Ignjatović, N.; Miličević, D.; Uskoković, D. Preparation of composite material BCP/DLPLG with a different content of ceramic and polymer component. Proceedings of the 8th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Antić-Jovanović, A. Eds. 2006, Vol II, 498-500.
38. Najman, S.; Savić, V.; Djordjević, L.J.; Ignjatović, N.; Uskoković, D. Biological evaluation of hydroxyapatite/Poly-L-lactide (HAp/PLLA) composite biomaterials with poly-L-lactide of different molecular weights intraperitoneally implanted into mice. Bio Med. Mater. Eng., 2004, 14, 61-70.
39. Ribeiro-Costa, R.; Alves, A.; Santos, N.; Nascimento, S.; Goncalves, E.; Silva, N.; Honda, N. K.; Santos-Magalhñaes, N. S. In vitro and in vivo properties of usnic acid encapsulated into PLGA-microspheres. J. Microencapsul., 2004, 21 (4), 371-384.
40. Zhou, S.; Song, B.; Li, X. In vitro degradation and release profiles for polydl-lactide film containing paracetamol. J. Mater. Sci. Mater. Med., 2007, 18 (8), 1623-1626.
41. Day, R. M.; Boccaccini, A. R.; Maquet, V.; Shurey, S.; Forbes, A.; Gabe, S. M.; Jérôme, R. In vivo charaterisation of a novel bioresorbable poly(lactide-co-glycolide) tubular foam scaffold for tissue engineering applications. J. Mater. Sci. Mater. Med., 2004, 15 (6), 729-734.
42. Miller, R. A.; Brady, J. M.; Cutright, D. E.; Degradation rates of oral resorbable implants (polylactates and polyglycolates):rate modification with changes in PLA/PGA copolymer ratios. J. Biomed. Mater. Res., 1977, 11(5), 711-719.
43. Kaihara, S.; Matsumura, S.; Mikos, A. G.; Fisher, J. P. Synthesis of poly(L-lactide) and polyglycolide by ring-opening polymerization. Nat. Protoc., 2007, 2, 2767-2771.
44. Dorta, M. J.; Manguia, O.; Llabres, M. Effects of polymerization variables on PLGA properties: molecular weight, composition, and chain structure. Int. J. Pharm., 1993, 100, 9-14.
45. Edlund, U.; Albertsson, A. C. Polyesters based on diacid monomers. Adv. Drug Deliv. Rev., 2003, 55, 585-609.
46. Kricheldorf, H. R. Syntheses and application of polylactides. Chemosphere, 2001, 43, 49-54.
47. Park, T. T. Degradation of poly (lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials, 1995, 16, 1123-1130.
48. Anderson, J. M.; Shive, M. S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev., 1997, 28 (1), 5-24.
49. Jiang, W.; Gupta, R. K.; Deshpande, M. C.; Schwendeman, S. P. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv. Drug Deliv. Rev., 2005, 57 (3), 391-410.
50. Vainionpä, S.; Rokkanen, P.; Törmälä, P. Surgical applications of biodegradable polymers in human tissues. Prog. Polym. Sci., 1989, 14, 679-716.
51. Suuronen, R.; Haers, P.; Lindqvist, C.; Sailer, H. Update on bioresorbable plates in maxillofacial surgery. Fac. Plast. Surg., 1999, 15 (1), 61-72.
52. Ignjatović, N.; Savić, V.; Najman, S.; Plavšić, M.; Uskoković, D. A study of HAp/PLLA composite as a substitute for bone powder, using FT-IR spectroscopy. Biomaterials, 2001, 22, 571-575.
53. Jain, R. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000, 21(23), 2475-2490.
54. Gilding, D. K.; Reed, A. M. Biodegradable polymers for use in surgery-polyglycolic/poly(actic acid) homo- and copolymers: 1. Polymer, 1979, 20, 1459-1464.
55. Omelczuk, M. O.; McGinity, J. W. The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(dl-lactic acid). Pharm. Res., 1992, 9, 26-32.
56. Miller, R. A.; Brady, J. M.; Cutright, D. E. Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in pla/pga copolymer ratios. J. Biomed. Mater. Res., 1977, 11, 711-719.
57. van Vaeck, L.; Adriaens, A.; Gijbels, R. Static secondary ion mass spectrometry: (s-sims) part 1. Methology and stuctural interpretation. Mass Spectrom. Rev., 1999, 18, 1-47.
58. Shard, A. G.; Clarke, S.; Davies, M. C. Static sims analysis of random poly (lactic-co-glycolic acid). Surf. Interface Anal., 2002, 33, 528-532.
59. Loo, S.; Ooi, C.; Boey, Y. Influence of electron-beam radiation on the hydrolytic degradation behaviour of poly(lactide-co-glycolide) (PLGA). Biomaterials, 2004, 26 (18), 3809-3817.
60. Raghuvanshi, R.; Singh, M.; Talwar, G. Biodegradable delivery system for single step immunization with tetanus toxoid. Int. J. Pharm., 1993, 93, R 1-5.
61. Gratton, S. E. A.; Pohlhaus, P. D.; Lee, J.; Guo, J.; Cho, M. J.; De Simone, J. M.; Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT™ nanoparticles. J. Control. Release, 2007, 121(1-2), 10-18.
62. Mishima, K. Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas. Adv. Drug Deliv. Rev., 2008, 60 (3), 411-432.
63. Kang, Y.; Yin, G.; Ouyang, P.; Huang, Z.; Yao, Y.; Liao, X.; Chen, A.; Pu, X. Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS). J. Colloid Interface Sci., 2008, 322 (1), 87-94.
64. 53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol. Pharmacol., 2004, 1, 211-219.
65. Sahoo, S. K.; Labhasetwar, V.; Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharmacol., 2005, 2, 373-383.
66. Song, K. C.; Lee, H. S.; Choung, I. Y.; Cho, K. I.; Ahn, Y.; Choi, E. J. The effect type of organic phase solvents on the particle size of poly(D,L-lactide-coglycolide) nanoparticles. Colloids Surf. A., 2006, 276, 162-167.
67. Astete, C. E.; Kumar, C. S. S. R.; Sabliov, C. M. Size control of poly(D,Llactide-coglycolide) and poly(D,L-lactide-co-glycolide)-magnetite nanoparticles synthesized by emulsion evaporation technique. Colloids Surf. A, 2007, 299, 209-216.
68. Lee, S. J.; Jeong, J. R.; Shin, S. C.; Kim, J. C.; Chang, Y. H.; Lee, K. H.; Kim, J. D. Magnetic enhancement of iron oxide nanoparticles encapsulated with poly(D,L-lactide-co-glycolide). Colloids Surf. A., 2005, 255, 19-25.
69. Bilati, U.; Allémann, E.; Doelker, E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur. J. Pharm. Sci., 2005, 24, 67-75.
70. Govender, T.; Stolnik, S.; Garnett, M. C.; Illum, L.; Davis, S. S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release, 1999, 57, 171-185.
71. Rivera, P. A.; Martinez-Oharriz, M. C.; Rubio, M.; Irache, J. M.; Espuelas, S.; Fluconazole encapsulation in PLGA microspheres by spray-drying. J. Microencapsul., 2004, 21 (2), 203-211.
72. Atuah, K. N.; Walter, E.; Merkle, H. P.; Alpar, H. O. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods. J. Microencapsul., 2003, 20(3), 387-399.
73. Takashima, Y.; Saito, R.; Nakajima, A.; Oda, M.; Kimura, A.; Kanazawa, T.; Okada, H. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres. Int. J. Pharm., 2007, 343(1-2), 262-269.
74. Cheng, F. Y.; Wang, S. P. H.; Su, C. H.; Tsai, T. L.; Wu, P. C.; Shieh, D. B.; Chen, J.-H.; Hsieh, P. C.-H.; Yeh, C.-S. Stabilizer-free poly(lactide-coglycolide) nanoparticles for multimodal biomedical probes. Biomaterials, 2008, 29, 2104-2112.
75. Kwon, H. Y.; Lee, J. Y.; Choi, S. W.; Jang. Y.; Kim, J. H. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf. A, 2001, 182, 123-130.
76. Zambaux, M.; Bonneaux, F.; Gref, R.; Maincent, P.; Dellacherie, E.; Alonso, M.; Labrude, B.; Vigneron, C.; Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by double emulsion method. J. Control. Release, 1998, 50, 31-40.
77. Stevanović, M.; Ignjatović, N.; Jordović, B.; Uskoković, D. Stereological analysis of the poly (DL-lactide-co-glycolide) submicron sphere prepared by solvent/ non-solvent chemical methods and centrifugal processing. J. Mater. Sci. Mater. Med., 2007, 18 (7), 1339-1344.
78. Niwa, T.; Takeuchi, H.; Hino, T.; Kunou, N.; Kawashima, Y. Preparation of biodegradable nanoparticles of water-soluble and insoluble drugs with D,L lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behaviour. J. Control. Release, 1993, 25, 89-98.
79. Thomasin, C.; Nam- Tran, H.; Merkle, H. P.; Gander, B. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations. J. Pharm. Sci., 1998, 87(3), 259-268.
80. Thomasin, C.; Merkle, H. P.; Gander, B. Drug microencapsulation by PLA/ PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation. J. Pharm. Sci., 1998, 87 (3), 269-275.
81. Gander, B.; Johansen, P.; Nam-Tran, H.; Merkle, H. P. Thermodynamic approach to protein microencapsulation into poly(D,L-lactide) by spray drying. Int. J. Pharm., 1996, 129, 51-61.
82. Tamber, H.; Johansen, P.; Merkle, H. P.; Gander, B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv. Drug Deliv. Rev., 2005, 57 (3), 357-376.
83. Park, J. H.; Choi, S. O.; Kamath, R.; Yoon, Y. K.; Allen, M.; Prausnitz, M. Polymer particle-based micromolding to fabricate novel microstructures. Biomed. Microdevices., 2007, 9 (2), 223-234.
84. Choi, Y.; Park, S.; Suh, H. Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials, 2005, 26, 5855-5863.
85. Martinez-Sancho, C.; Herrero-Vanrell, R.; Negro, S. Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration. J. Control. Release, 2004, 99, 41-52.
86. Daugherty, A.; Cleland, J.; Duenas, E.; Mrsny, R.; Pharmacological modulation of the tissue response to implanted polylactic-co-glycolic acid microspheres. Eur. J. Pharm. Biopharm., 1997, 44 (1), 89-102.
87. Jeong, Y.; Song, J.; Kang, S.; Ryu, H.; Lee, Y.; Choi, C.; Shin, B.-A.; Kim, K.-K.; Ahn, K.-Y.; Jung, S. Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. Int. J. Pharm., 2003, 259, 79-91.
88. Liu, J.; Meisner, D.; Kwong, E.; Wu, X. Y.; Johnston, M. R. A novel translymphatic drug delivery system: Implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Biomaterials, 2007, 28 (21), 3236-3244.
89. Feng, S. S.; Mu, L.; Yin Win, K.; Huang, G. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr. Med. Chem., 2004, 11, 413-424.
90. Murakami, H.; Kobayashi, M.; Takeuchi, H.; Kawashima, Y. Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles. Powder Technol., 2000, 107, 137-143.
91. Ignjatović, N. L.; Liu, C. Z.; Czernuszka, J. T.; Uskoković, D. P. Micro- and nano-injectable composite biomaterials containing calcium phosphate coated with poly(dl-lactide-co-glycolide). Acta Biomater., 2007, 3 (6), 927-935.
92. Jevtić, M.; Mitrić, M.; Škapin, S.; Jančar B.; Ignjatović, N.; Uskoković, D. Crystal structure of hydroxyapatite nano-rods synthesized by sonochemical homogenous precipitation. Cryst. Growth Des., 2008, 8(7), 2217-2222.
93. Uskoković, P. S.; Tang, C. Y.; Tsui, C. P.; Ignjatović, N.; Uskoković, D. Micromechanical properties of a hydroxyapatite/ poly-L-lactide biocomposite using nano-indentation and modulus maping. J. Eur. Ceram. Soc., 2007, 27, 1559-1564.
94. Ignjatović, N.; Suljovrujić, E.; Budimski, J.; Krakovsky, I.; Uskoković, D. Evaluation of hot pressed hydroxyapatite/ poly-l-lactide composite biomaterial. J. Biomed. Mater. Res. B, 2004, 71B, 284-294.
95. Jevtić, M.; Radulović, A.; Ignjatović, N.; Mitrić, M.; Uskoković, D. Controlled assembly of poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres under ultrasonic irradiation. Acta Biomater., 2008, 5(1), 208-218.
96. Jin, C.; Bai, L.; Wu, H.; Tian, F.; Guo, G. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro. Biomaterials, 2007, 28 (25), 3724-3730.
97. Stevanović, M. M.; Jordović, B.; Uskoković, D. P. Preparation and characterization of poly(D,L-lactide-co-glycolide) nanoparticles containing ascorbic acid. J. Biomed. Biotechnol., 2007, doi:10.1155/2007/84965
98. Feczkó, T.; Tóth, J.; Gyenis, J. Comparison of the preparation of PLGA-BSA nano- and microparticles by PVA, poloxamer and PVP. Colloids Surf A, 2008, 319, 188-195.
99. Wina, K. Y.; Feng, S. S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 2005, 26, 2713-2722.
100. Jani, P.; Halbert, G. W.; Langridge, J.; Florence, T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol., 1989, 41, 809-812.
101. Jani, P. U.; Halbert, G. W.; Langridge, J.; Florence, A. T. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J. Pharm. Pharmacol., 1990, 42, 821-826.
102. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable long-circulating polymeric nanospheres. Science, 1994, 263 (5153), 1600-1603.
103. Lemarchand, C.; Gref, R.; Couvreu, P. Polysaccharide-decorated nanoparticles. Eur. J. Pharm. Biopharm., 2004, 58 (2), 327-341.
104. Dhand, R. Future directions in aerosol therapy. Respir. Care Clin. North Am., 2001, 7, 319-335.
105. Makino, K.; Nakajima, T.; Shikamura, M.; Ito, F.; Ando, S.; Kochi, C.; Inagawa, H.; Soma, G.-I.; Terada, H. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloids Surf. B, 2004, 36 (1), 35-42.
106. Tomoda, K.; Ohkoshi, T.; Kawai, Y.; Nishiwaki, M.; Nakajima, T.; Makino, K. Preparation and properties of inhalable nanocomposite particles: Effects of the temperature at a spray-dryer inlet upon the properties of particles. Colloids Surf. B, 2008, 61 (2), 138-144.
107. Soppimatha, K. S.; Aminabhavia, T. M.; Kulkarnia, A. R.; Rudzinski, W. E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release, 2001, 70, 1-20.
108. Govender, T.; Riley, T.; Ehtezazi, T.; Garnett, M, C.; Stolnik, S.; Illum, L.; Davis, S. S. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int. J. Pharm., 2000, 199, 95-110.
109. Panyam, J.; Williams, D.; Dash, A.; Leslie-Pelecky, D.; Labhasetwar, V. Solid-state solubility influences ncapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J. Pharm. Sci., 2004, 93, 1804-1814.
110. Katsikogianni, G.; Avgoustakis, K. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties. J. Nanosci. Nanotechnol., 2006, 6 (9-10), 3080-3086.
111. Freiberg, S.; Zhu, X. X. Polymer microspheres for controlled drug release. Int. J. Pharm., 2004, 282, 1-18.
112. Matsumoto, A.; Matsukawa, Y.; Suzuki, T.; Yoshino, H. Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-coglycolide) and poly(dl-lactide). J. Control. Release, 2005, 106 (1-2), 172-180.
113. Taylor, D. J. F.; Thomas, R. K.; Penfold, J. Polymer/surfactant interactions at the air/water interface. Adv. Colloid Interface Sci., 2007, 132, 69-110.
114. Biasutti, M. A.; Abuin, E. B.; Silber, J. J.; Correa, N. M.; Lissi, E. A. Kinetics of reactions catalyzed by enzymes in solutions of surfactants. Adv. Colloid Interface Sci., 2008, 136, 1-24.
115. Fonseca, C.; Simões, S.; Gaspar, R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vivo anti-tumoral activity. J. Control. Release, 2002, 83, 273-286.
116. Saxena, V.; Sadoqi, M.; Shao, J. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Int. J. Pharm., 2004, 278, 293-301.
117. Kim, S. H.; Jeong, J. H.; Chun, K. W.; Park, T. G. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir, 2005, 21, 8852-8827.
118. Song, K. C.; Lee, H. S.; Choung, I. Y.; Cho, K. I.; Ahn, Y.; Choi, E. J. The effect type of organic phase solvents on the particle size of poly(D,L-lactide-coglycolide) nanoparticles. Colloids Surf. A, 2006, 276, 162-167.
119. Quintanar-Guerrero, D.; Allemann, E.; Fessi, H.; Doclker, E. Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm., 1998, 24, 1113-1128.
120. Chun, K. W.; Yoo, H. S.; Yoon, J. J.; Park, T. G. Biodegradable PLGA microcarriers for injectable delivery of chondrocytes: effect of surface modification on cell attachment and function. Biotechnol. Prog., 2004, 20, 1797-1801.
121. Jovanović, I.; Jordović, B.; Petković, M.; Ignjatović, N.; Uskoković, D. Preparation of smallest microparticles of poly-D,L-lactide by modified precipitation method: influence of the process parameters. Microsc. Res.Tech., 2007, 71 (2), 86-92.
122. Stevanović, M.; Jordović, B.; Nedić, Z.; Miličević, D. The stabilizer influence on morphological characteristics of poly (DL-lactide-co-glycolide) nanospheres. Mater. Sci. Forum, 2007, 555, 447-452.
123. Feng, S. S.; Huang, G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. J. Control. Release, 2001, 71, 53-69.
124. Chung, T. W; Tsai, Y. L.; Hsieh, J. H.; Tsai, W. J. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. J. Microencapsul., 2006, 23 (1), 15-27.
125. Mu, L.; Feng, S. S. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxols). J. Control. Release, 2002, 80 (1-3), 129-144.
126. Mu, L.; Feng, S. S. A novel controlled release formulation for anticancer drug paclitaxel (Taxols): PLGA nanoparticles containing vitamin E TPGS. J. Control. Release, 2003, 86 (1), 33-48.
127. Mu, L.; Feng S. S. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and the drug loading ratio. Pharm. Res., 2003, 20 (11), 1864-1872.
128. Arakawa, T.; Kita Y. Protection of bovine serum albumin from aggregation by Tween 80. J. Pharm. Sci., 2000, 89, 646-651.
129. Vandervoort, J.; Ludwig, A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int. J. Pharm., 2002, 238 (1-2), 77-92.
130. Kwon, H. Y.; Lee, J. Y.; Choi, S. W.; Jang, Y.; Kim, J. H. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf. A, 2001, 182 (1-3), 123-130.
131. Weiss, B.; Schneider, M.; Muys, L.; Taetz, S.; Neumann, D.; Scharfer, U. F.; Lehr, C. M. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-coglycolide) nanoparticles for versatile surface modification. Bioconjug. Chem., 2007, 18, 1087-1094.
132. Sakai, T. Surfactant-free emulsions. Curr. Opin. Colloid Interface Sci., 2008, 13 (4), 228-235.
133. Ikada, Y. Polymeric biomaterials research. Adv. Eng. Mater., 1999, 1 (1), 67-68.
134. Ratner, B. D. Surface modification of polymers: chemical, biological and surface analytical challenges. Biosens. Bioelectron., 1995, 10, 797-804.
135. Béduneau, A.; Saulnier, P.; Benoit, J. P. Active targeting of brain tumors using nanocarriers. Biomaterials, 2007, 28, 4947-4967.
136. Moghimi, S. M.; Patel, H. M. Differential properties of organ-specific serum opsonins for liver and spleen macrophages. Biochim. Biophys. Acta, 1989, 984 (3), 379-383.
137. Illum, L.; Jacobsen, L. O.; Muller, R. H.; Mak, E.; Davis, S. S. Surface characteristics and the interaction of colloidal particles with mouse peritoneal-macrophages. Biomaterials, 1987, 8, 113-117.
138. Martínez Gómez, J. M.; Csaba, N.; Fischer, S.; Sichelstiel, A.; Kündig, T. M.; Gander, B.; Johansen, P. Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. J. Control. Release, 2008, 130(2), 161-167.
139. Moghimi, S. M.; Porter, C. J. H.; Muir, I. S.; IIIum, L.; Davis, S. S. Nonphagocytic uptake of intravenously injected microspheres in rat spleen - influence of particle-size and hydrophilic coating. Biochem. Biophys. Res. Commun., 1999, 177, 861-866.
140. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable long-circulating polymeric nanospheres. Science, 1994, 263 (5153), 1600-1603.
141. Lemarchand, C.; Gref, R.; Passirani, C.; Garcion, E.; Petri, B.; Müller, R.; Costantini, D.; Couvreur, P. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials, 2006, 27 (1), 108-118.
142. Gibaud, S.; Andreux, J. P.; Weingarten, C.; Renard, M.; Couvreur, P. Increased bone marrow toxicity of doxorubicin bound to nanoparticles. Eur. J. Cancer, 1994, 30A (6), 820-826.
143. Demoy, M.; Gibaud, S.; Andreux, J. P.; Weingarten, C.; Gouritin, B.; Couvreur, P. Splenic trapping of nanoparticles: complementary approaches for in situ studies. Pharm. Res., 1997, 14 (4), 463-468.
144. Goddard, J. M.; Hotchkiss, J. H. Polymer surface modification for the attachment of bioactive compounds. Prog. Polym. Sci., 2007, 32 (7), 698-725.
145. Stevanović, M.; Radulović, A.; Jordović, B.; Uskoković, D. Poly(DL-lactide-co-glycolide) nanospheres for potential sustained release of folic acid. J. Biomed. Nanotechnol., 2008, 4 (3), 349-358.
146. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov., 2003, 2, 347-360.
147. Khandre, J.; Minko, T. Polymer-drug conjugates: Progress in polymeric prodrugs. Prog. Polym. Sci., 2006, 31, 359-397.
148. Cheng, J.; Teply, B. A.; Sherifi, I.; Sung, J.; Luther, G.; Gu, F. X.; Levy-Nissenbaum, E.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 2007, 28, 869-876.
149. Lupold, S. E.; Hicke, B. J.; Lin, Y.; Coffey, D. S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res., 2002, 62 (14), 4029-4033.
150. Farokhzad, O. C.; Jon, S. Y.; Khadelmhosseini, A.; Tran, T. N. T.; LaVan, D. A.; Langer R. Nanopartide-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res., 2004, 64 (21), 7668-7672.
151. Yoo, H. S.; Park, T. G. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Release, 2004, 96 (2), 273-283.
152. Paulos, C. M.; Reddy, J. A.; Leamon, C. P.; Turk, M. J.; Low, P. S. Ligand binding and kinetics of folate receptor recycling in vivo: Impact on receptor-mediated drug delivery. Mol. Pharmacol., 2004, 66, 1406-1414.
153. Hattori, Y.; Maitani, Y. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther., 2005, 12, 796-809.
154. Bae, Y.; Jang, W. D.; Nishiyama, N.; Fukushima, S.; Kataoka, K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Biosyst., 2005, 1, 242-250.
155. Sudimack, J.; Lee, R. J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev., 2000, 41, 147-162.
156. Zhang, J.; Rana, S.; Srivastava, R. S.; Misra, R. D. K. On the chemical and drug delivery response of folate receptor-activated, polyethylene glycol-funcionalized magnetite nanoparticles. Acta Biomater., 2008, 4, 40-48.
157. Moore, A.; Basilion, J. P.; Chiocca, E. A.; Weissleder, R. Measuring transferrin receptor gene expression by NMR imaging. Biochim. Biophys. Acta, 1998, 1402 (3), 239-249.
158. Wang, X.; Wenk, E.; Hu, X.; Castro, G. R.; Meinel, L.; Wang, X.; Li, C.; Merkle, H.; Kaplan, D. L. Silk coatings on PLGA, and alginate microspheres for protein delivery. Biomaterials, 2007, 28 (28), 4161-4169.
159. Choi, S. W.; Kim, J. H. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J. Control. Release, 2007, 122 (1), 24-30.
160. Fischer, S.; Foerg, C.; Ellenberger, S.; Merkle, H. P.; Gander, B. One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. J. Control. Release, 2006, 111 (1-2), 135-144.
161. Thanki, P. N.; Dellacherie, E.; Six, J. L. Surface characteristics of PLA and PLGA films. Appl. Surf. Sci., 2006, 253 (5), 2758-2764.
162. Zhu, A. P.; Fang, N.; Chan-Park, M. B.; Chan, V. Adhesion contact dynamics of 3T3 fibroblasts on poly(lactide-co-glycolide acid) surface modified by photochemical immobilization of biomacromolecules. Biomaterials, 2006, 27 (12), 2566-2576.
163. Zheng, Y. F.; Li, C.; Li, C. J.; Cai, W.; Zhao, L. C. Surface characteristics and biological properties of paclitaxel-embedding PLGA coatings on TiNi alloy. Mater. Sci. Eng. A, 2006, 438-440, 1119-1123.
164. Tosi, G.; Rivasi, F.; Gandolfi, F.; Costantino, L.; Vandelli, M. A.;
165. Keegan, M. E.; Royce, S. M.; Fahmy, T.; Saltzman, W. M. In vitro evaluation of biodegradable microspheres with surface-bound ligands. J. Control. Release, 2006, 110 (3), 574-580.
166. Denis-Mize, K. S.; Dupuis, M.; MacKichan, M. L.; Singh, M.; Doe, B.; O'Hagan, D.; Ulmer, J. B.; Donnelly, J. J.; McDonald, D. M.; Ott, G. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther., 2000, 7 (24), 2105-2112.
167. Chiou, S. H.; Wu, W. T.; Huang, Y. Y.; Chung, T. W. Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres. J. Microencapsul., 2001, 18 (5), 613-625.
168. Mandal, B.; Kempf, M.; Merkle, H. P.; Walter, E. Immobilisation of GMCSF onto particulate vaccine carrier systems. Int. J. Pharm., 2004, 269 (1), 259-265.
169. Chandy, T.; Das, G. S.; Rao, G. H. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J. Microencapsul., 2000, 17 (5), 625-638.
170. Holy, C. E.; Dang, S. M.; Davies, J. E.; Shoichet, M. S. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam. Biomaterials, 1999, 20 (13), 1177-1185.
171. Lu, L.; Peter, S. J.; Lyman, M. D.; Lai, H. L.; Leite, S. M.; Tamada, J. A.; Uyama, S.; Vacanti, J. P.; Langer, R.; Mikos, A. G. In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams. Biomaterials, 2000, 21 (18), 1837-1845.
172. Budhian, A.; Siegel, S. J.; Winey, K. I.; Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int. J. Pharm., 2008, 346 (1-2), 151-159.
173. Fambri, L.; Migliares, C.; Kesenci, K.; Piskin, E. In Biodegradable polymers, Integrated biomaterials science, Barbucci, R., Ed.; Springer US, 2002, pp. 119-187.
174. Therin, M.; Christel, P.; Li, S.; Garreau, H.; Vert, M. In vivo degradation of massive poly(alphahydroxy acids): Validation of in vitro findings. Biomaterials, 1992, 13 (9), 594-600.
175. Kiss, E.; Vargha-Butler, E. I. Novel method to characterize the hydrolytic decomposition of biopolymer surfaces. Colloids Surf. B, 1999, 15 (3-4), 181-193.
176. Stevanović, M. M.; Jordović, B.; Uskoković, D. P. Morphological changes of poly(DL-lactide-co-glycolide) nanoparticles containing ascorbic acid during in vitro degradation process. J. Microsc., 2008, accepted.
177. Wu, L.; Ding, J. In vitro degradation of three-dimensional porous poly (D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials, 2004, 25 (27), 5821-5830.
178. Dunne, M.; Corrigan, O. I.; Ramtoola, Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials, 2000, 21 (16), 1659-1668.
179. Hurrell, S.; Cameron, R. E. Polyglycolide: degradation and drug release. Part I: changes in morphology during degradation. J. Mater. Sci. Mater. Med., 2001, 12 (9), 811-816.
180. Göpferich, A. Mechanism of polymer degradation and erosion. Biomaterials, 1996, 17 (2), 103-114.
181. Xu, X.; Liu, T.; Zhang, K.; Liu, S.; Shen, Z.; Li, Y.; Jing, X. Biodegradation of poly(l-lactide-co-glycolide) tube stents in bile. Polym. Degrad. Stab., 2008, 93 (4), 811-817.
182. Stevanović, M.; Jordović, B.; Uskoković, D. Stereological analysis of DLPLG nanoparticles containing ascorbic acid during in vitro degradation process. Proceedings of the 3rd Serbian Congress for Microscopy (3scm-2007) Belgrade, Serbia, 25-28 September 2007, 153-154.
183. Xia, Z.; Huang, Y.; Adamopoulos, I. E.; Walpole, A.; Triffitt, J. T.; Cui, Z. Macrophage-mediated biodegradation of poly(DL-lactideco-glycolide) in vitro. J. Biomed. Mater. Res. A, 2006, 79(3), 582-590.
184. Bergsma, J. E.; de Bruijn, W. C.; Rozema, F. R.; Bos, R. R.; Boering, G. Late degradation tissue response to poly(L-lactic acid) bone plates and screws. Biomaterials, 1995, 16 (1), 25-31.
185. Grizzi, I.; Garreau, H.; Li, S.; Vert, M. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials, 1995, 16 (4), 305-311.
186. Avgoustakis, K.; Nixon, J. R. Biodegradable Controlled tablets 3. Effect of polymer characteristics on drug release. Int. J. Pharm., 1993, 99 (2-3), 247-252.
187. Vert, M.; Mauduit, J.; Li, S. Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials, 1994, 15 (15), 1209-1213.
188. Maniar, M.; Kalonia, D.; Simonelli, A. Determination of specific rate constants of specific oligomers during polyester hydrolysis. J. Pharm. Sci., 1991, 80 (8), 778-782.
189. Yoshioka, T.; Kawazoe, N.; Tateishi, T.; Chen, G. In vitro evaluation of biodegradation of poly(lactic-co-glycolic acid) sponges. Biomaterials, 2008, 29 (24-25), 3438-3443.
190. Husmann, M.; Schenderlein, S.; Lück, M.; Lindner, H.; Kleinebudde, P. Polymer erosion in PLGA microparticles produced by phase separation method. Int. J. Pharm., 2002, 242 (1-2), 277-280.
191. Kim, J.; Seo, K. S.; Jeong, Y. K.; Lee, H. B.; Kim, Y. S.; Gilson, K. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation. J. Biomater. Sci., 2005, 16 (8), 991-1007.
192. Sung, K. C.; Han, R. Y.; Hu, O. Y. P.; Hsu, L. R. Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition. Int. J. Pharm., 1998, 172 (91), 17-25.
193. Li, S.; Girod-Holland, S.; Vert, M. Hydrolytic degradation of poly(dl-lactic acid) in the presence of caffeine base. J. Control. Release, 1996, 40 (1-2), 41-54.
194. Frank, A.; Rath, S. K.; Venkatraman, S. S. Controlled release from bioerodible polymers: effect of drug type and polymer composition. J. Control. Release, 2005, 102 (2), 333-344.
195. Siegel, S. J.; Kahn, J. B.; Metzger, K.; Winey, K. I.; Werner, K.; Dan, N. Effect of drug type on the degradation rate of PLGA matrices. Eur. J. Pharm. Biopharm., 2006, 64 (3), 287-293.
196. Kempen, D. H. R.; Lu, L.; Hefferan, T. E.; Creemers, L. B.; Maran, A.; Classic, K. L.; Dhert, W. J. A.; Yaszemski, M. J. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials, 2008, 29 (22), 3245-3252.
197. Ranganath, S. H.; Wang, C. H. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma. Biomaterials, 2008, 29 (20), 2996-3003.
198. Rocha, F. G.; Sundback, C. A.; Krebs, N. J.; Leach, J. K.; Mooney, D. J.; Ashley, S. W.; Vacanti, J. P.; Whang, E. E. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials, 2008, 29 (19), 2884-2890.
199. Song, X.; Zhao, Y.; Hou, S.; Xu, F.; Zhao R.; He, J.; Cai, Z.; Li, Y.; Chen, Q. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur. J. Pharm. Biopharm., 2008, 69 (2), 445-453.
200. Faisant, N.; Akiki, J.; Siepmann, F.; Benoit, J. P.; Siepmann, J. Effects of the type of release medium on drug release from PLGA-based microparticles: Experiment and theory. Int. J. Pharm., 2006, 314 (2), 189-197.
201. Zolnik, B. S.; Burgess, D. J. Effect of acidic pH on PLGA microsphere degradation and release. J. Control. Release, 2007, 122 (3), 338-344.
202. Mundargi, R. C.; Babu, V. R.; Rangaswamy, V.; Patel, P.; Aminabhavi, T. M. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J. Control. Release, 2008, 125 (3), 193-209.
203. Li, L.; Schwendeman, S. P. Mapping neutral microclimate pH in PLGA microspheres. J. Control. Release, 2005, 101 (1-3), 163-173.
204. Fu, K.; Klibanov, A. M.; Langer, R. Protein stability in controlled-release systems. Nat. Biotechnol., 2000, 18, 24-25.
205. Fu, K.; Pack, D. W.; Klibanov, A. M.; Langer, R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res., 2000, 17 (1), 100-106.
206. Houchin, M. L.; Neuenswander, S. A.; Topp, E. M. Effect of Excipients on PLGA Film Degradation and the Stability of an Incorporated Peptide. J. Control. Release, 2007, 117 (3), 413-420.
207. Klose, D.; Siepmann, F.; Elkharraz, K.; Krenzlin, S.; Siepmann, J. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int. J. Pharm., 2006, 314 (2), 198-206.
208. He, J. T.; Su, H. B.; Li, G. P.; Tao, X. M.; Mo, W.; Song, H. Y. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-coglycolic acid) microspheres. Int. J. Pharm., 2006, 309 (1-2), 101-8.
209. Hedberg, E. L.; Kroese-Deutman, H. C.; Shih, C. K.; Crowther, R. S.; Carney, D. H.; Mikos, A. G.; Jansen, J. A. In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds. Biomaterials, 2005, 26 (22), 4616-4623.
210. Shum, A. W. T.; Li, J.; Mak, A. F. T. Fabrication and structural characterization of porous biodegradable poly(DL-lactic-co-glycolic acid) scaffolds with controlled range of pore sizes. Polym. Degrad. Stab., 2005, 87 (3), 487-493.
211. Li, J.; Mak, A. F. T. Transfer of collagen coating from porogen to scaffold: Collagen coating within poly(DL-lactic-co-glycolic acid) scaffold. Composites Part B, 2007, 38 (3), 317-323.
212. Orava, E.; Korventausta, J.; Rosenberg, M.; Jokinen, M.; Rosling, A. In vitro degradation of porous poly(DL-lactide-co-glycolide) (PLGA)/bioactive glass composite foams with a polar structure. Polym. Degrad. Stab., 2007, 92 (1), 14-23.
213. Rawat, A.; Majumder, Q. H.; Ahsan, F. Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluation. J. Control. Release, 2008, 128 (3), 224-232.
214. Arnold, M. M.; Gorman, E. M.; Schieber, L. J.; Munson, E. J.; Berkland, C. NanoCipro encapsulation in monodisperse large porous PLGA microparticles. J. Control. Release, 2007, 121 (1-2), 100-109.
215. Kim, H. K.; Chung, H. J.; Park, T. G. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. J. Control. Release, 2006, 112 (2), 167-174.
216. Naidu, K. A. Vitamin C in human health and disease is still a mystery? An overview. Nutr. J., 2003, 2 (7), 1-10.
217. Martinez-Sancho, C.; Herrero-Vanrell, R.; Negro, S. Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release. Int. J. Pharm., 2006, 326 (1-2), 100-106.
218. Ribeiro, H. S.; Chu, B. S.; Ichikawa, S.; Nakajima, M. Preparation of nano-dispersions containing β-carotene by solvent displacement method. Food Hydrocolloid., 2008, 22 (1), 12-17.
219. Hashida, M.; Hirabayashi, H.; Nishikawa, M.; Takakura Y. Targeted delivery of drugs and proteins to the liver via receptor-mediated endocytosis. J. Control. Release, 1997, 46 (1-2), 129-137.
220. Mu, L.; Feng, S. S. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J. Control. Release, 2003, 86 (1), 33-48.
221. Zhang, Z.; Feng, S. S. Self-assembled nanoparticles of poly(lactide)-vitamin E TPGS copolymers for oral chemotherapy. Int. J. Pharm., 2006, 324 (2), 191-198.
222. Mu, L.; Feng, S. S. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J. Control. Release, 2002, 80 (1-3), 129-144.
223. Suzuki, T.; Matsukawa, Z.; Suzuki, A. Method and apparatus for preparing microspheres. US Patent 7 011 776, March 2006.
224. Kafrissen, M. E.; Oakley, G. Pharmaceutical methods of delivering folic acid. US Patent 6 190 693, February 2001.
225. Zhao, H.; Yung, L. Y. L. Selectivity of folate conjugated polymer micelles against different tumor cells. Int. J. Pharm., 2008, 349 (1-2), 256-268.